The latest happenings of the past month, all in one place.
MMS announced the growth of its leadership team with the appointment of Kelly J. Hill to Executive Vice President of Global Business Operations and Strategy, and Michelle Gayari to Executive Vice President of Global Operational Excellence and Innovation. The company also announced that Arunima Sen, MD, Director of Pharmacovigilance and Medical Writing (India), has been appointed to the Indian Society of Clinical Research’s Pharmacovigilance Council.
CTMA has appointed Arnaud Marcel as the new Chief Technology Officer.
Calyx announced that Craig M. Mooney joined the company as Vice President of Science and e-Tech Enabled Services.
PHASTAR announced the appointment of Chuck Gelb as Chief Commercial Officer.
Steve Rosenberg has joined uMotif's Board of Directors.
Imaging Endpoints announced that it has established a new office located in the Vorstaedte District of Basel, Switzerland.
THREAD has been awarded Frost & Sullivan’s 2021 Customer Value Leadership Award. Additionally the company has announced that worldwide analyst Everest Group has deemed them a Leader in the DCT sector.
Sensyne Health plc has reached a milestone of access to a combined clinical research, clinical trial, and real world de-identified and anonymized dataset of over 60 million patients.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.